Showing results (111-120 of 177) with videos related to
Sort By:
Pageof 18
Arthritis & Rheumatology (Hoboken, N.J.)|August 20, 2020
Representation of Women as Authors of Rheumatology Research ArticlesEkta Bagga, Sarah Stewart, Gregory D Gamble, et al.Endocrinology|November 26, 2002
The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinaseAndrew Grey, Qi Chen, Karen Callon, et al.European Journal of Endocrinology|August 18, 2009
Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP geneJuliet E Jennings, Marianthi Georgitsi, Ian Holdaway, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled TrialAndrew Grey, Mark J Bolland, Anne Horne, et al.The American Journal of Clinical Nutrition|July 25, 2014
Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysisJohn A Ford, Graeme S MacLennan, Alison Avenell, et al.Annals of Clinical Biochemistry|January 25, 2025
Biochemical osteomalacia in adults undergoing vitamin D testing in the North-East of ScotlandAngus D Macleod, Mark J Bolland, Andrew Balfour, et al.Bonekey Reports|August 17, 2013
Subgroup analysis for the risk of cardiovascular disease with calcium supplementsLoretta T Radford, Mark J Bolland, Greg D Gamble, et al.The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal womenAndrew Grey, Mark J Bolland, Diana Wattie, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 10, 2016
Changing perceptions and efficacy of generic medicines: An intervention studySarah L E Colgan, Kate Faasse, Jennifer A Pereira, et al.European Journal of Endocrinology|March 13, 2012
Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trialAndrew Grey, Vaughan Beckley, Anthony Doyle, et al.Pageof 18